The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.
Bayer today announced that the U.S. Food and Drug Administration (FDA) approved AMBELVIST® (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) indicated for ...
Bayer gets approval for low-dose MRI contrast agent gadoquatrane in US: Berlin Tuesday, June 16, 2026, 12:00 Hrs [IST] Bayer has announced that the US Food and Drug Administration ...
Reveal's New Manganese-Based MRI Contrast Agent Advances Safer Patient Care · globenewswire.com CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the ...
Intestinal ultrasound demonstrates strong agreement with MRI in assessing Crohn’s disease activity, supporting its use as a ...
People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions ...
You can keep your best guesses. Engineers at Rice University's George R. Brown School of Engineering are starting to understand exactly what goes on when doctors pump contrast agents into your body ...
Contrast agents used to improve views of the heart on MRI carry a very low risk of allergic reactions, vomiting and other acute adverse events, according to a large study from Europe published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results